Maaike Kempes

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

Social network site addiction, sleep quality, depression and adolescent difficulty describing feelings: a moderated mediation model

Unzipping empathy in psychopathy: Empathy and facial affect processing in psychopaths

Reactive and proactive aggression in children A review of theory, findings and the relevance for child and adolescent psychiatry